Antibodies, Neoplasm
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Nivolumab in Relapsed Pediatric Solid Tumors (NCT02901145) | Hadassah Medical Organization | 2016-11-01 |
Track Antibodies, Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.